Table 3.
Prevalence of bacteria among UTI patents with history of catheterization and prophylaxis use at Felege Hiwot Referral hospital (April to August, 2010) n = 118
| Bacterial Isolates No. bacterial | Category | ||||
| Isolates (%) | Catheterized (85) |
Non-catheterized (33) |
Prophylaxis used (54) |
No prophylaxis used (64) |
|
| Gram-negative | |||||
| E. coli | 33 (28.0) | 28 | 5 | 16 | 17 |
| K. pneumonia | 24 (20.3) | 18 | 6 | 12 | 12 |
| Proteus mirabilis | 7 (5.9) | 6 | 1 | 1 | 6 |
| Enterobacter spp. | 3 (2.5) | 2 | 1 | 1 | 2 |
| Proteus vulgaris | 2 (1.7) | 0 | 2 | 1 | 1 |
| P. aeruginosa | 2 (1.7) | 2 | 0 | 0 | 2 |
| S. marcescens | 2 (1.7) | 2 | 0 | 0 | 2 |
| Gram-positive | |||||
| S. aureus | 33 (28.0) | 23 | 10 | 17 | 16 |
| Enterococcus spp. | 8 (6.8) | 7 | 1 | 3 | 5 |
| CNS | 3 (2.5) | 0 | 3 | 2 | 1 |
| Mixed Infection | 1 (0.8) | 1 | 0 | 0 | 1 |
CNS= Coagulase negative staphylococci